Scienture Holdings, Inc. (SCNX) — 10-Q Filings
All 10-Q filings from Scienture Holdings, Inc.. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
-
SCNX Revenue Soars 809% Amidst Widening Losses, Strategic Shift
— Nov 12, 2025 Risk: high
Scienture Holdings, Inc. (SCNX) reported a significant increase in revenue for the three months ended September 30, 2025, reaching $590,050, up from $64,861 in -
Scienture Holdings Navigates Complex Capital Structure in Q2
— Aug 12, 2025 Risk: high
Scienture Holdings, Inc. (SCNX) filed its 10-Q for the period ending June 30, 2025, revealing a complex financial landscape. The company's revenue figures were -
Scienture Holdings, Inc. Files Q1 2025 10-Q
— May 12, 2025 Risk: low
Scienture Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as TRxADE HEALTH, INC., is in the pharmaceutical prepa -
Scienture Holdings, Inc. Files Q3 2024 Report
— Nov 6, 2024 Risk: low
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) filed its quarterly report for the period ending September 30, 2024. The company's common stock trades u -
TRxADE HEALTH Files Q2 2024 10-Q
— Aug 9, 2024 Risk: medium
TRxADE HEALTH, INC. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as TRXADE GROUP, INC., is involved in the wholesale of drugs -
TRxADE HEALTH Files Q1 2024 10-Q
— Jun 26, 2024 Risk: low
TRxADE HEALTH, INC. filed its quarterly report for the period ending March 31, 2024. The company, formerly known as TRXADE GROUP, INC., is based in Lutz, Florid -
TRxADE HEALTH, INC. Files 10-Q for Period Ending September 30, 2023
— Jan 16, 2024 Risk: low
TRxADE HEALTH, INC (SCNX) filed a Quarterly Report (10-Q) with the SEC on January 16, 2024. TRxADE HEALTH, INC. filed a 10-Q report for the period ending Septem
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX